Lennart Beckmann
Dr. med.
Lennart Beckmann
  • Assistenzarzt
Arbeitsbereich

Kontakt

Standort

O24
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Auszeichnungen

Publikationen

Zurück
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2017
Vor

Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria
Beckmann L, Faizy T, Flottmann F, Fiehler J, Bokemeyer C, Well L, Beitzen-Heineke A, Langer F
HAMOSTASEOLOGIE. 2024.

Comparison of assays measuring extracellular vesicle-tissue factor in plasma samples: Communication from the ISTH SSC Subcommittee on Vascular Biology
Bonifay A, Mackman N, Hisada Y, Sachetto A, Hau C, Gray E, Hogwood J, Aharon A, Badimon L, Barile L, Baudar J, Beckmann L, Benedikter B, Bolis S, Bouriche T, Brambilla M, Burrello J, Camera M, Campello E, Ettelaie C, Faille D, Featherby S, Franco C, Guldenpfennig M, Hansen J, Judicone C, Kim Y, Kristensen S, Laakmann K, Langer F, Latysheva N, Lucien F, de Menezes E, Mullier F, Norris P, Nybo J, Orbe J, Osterud B, Paramo J, Radu C, Roncal C, Samadi N, Snir O, Suades R, Wahlund C, Chareyre C, Abdili E, Martinod K, Thaler J, Dignat-George F, Nieuwland R, Lacroix R
J THROMB HAEMOST. 2024 [Epub ahead of print].

Effect of factor XI inhibition on tumor cell-induced coagulation activation
Mäder J, Rolling C, Voigtländer M, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Beckmann L, Langer F
J THROMB HAEMOST. 2024;22(1):199-212.

Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer
Beckmann L, Lennartz M, Poch A, Holstein K, Bokemeyer C, Langer F
HAMOSTASEOLOGIE. 2023;43(4):289-296.

Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase
Langer F, Quick H, Beitzen-Heineke A, Janjetovic S, Mäder J, Lehr C, Bokemeyer C, Kuta P, Renné T, Fiedler W, Beckmann L, Klingler F, Rolling C
THROMB RES. 2023;229:155-163.

Purpura Fulminans Triggered by the Formation of Anti-Endothelial Autoantibodies in a Patient with Chronic Lymphocytic Leukemia
Beckmann L, Lennartz M, Beitzen-Heineke A, Voigtländer M, Rolling C, Holstein K, Bokemeyer C, Amirkhosravi A, Langer F
Ann Hematol Oncol. 2022;9(1):.

Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms
Beckmann L, Mäder J, Voigtlaender M, Klingler F, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Ruf W, Rolling C, Langer F
THROMB RES. 2022;220:48-59.

PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression
Mäder J, Voigtländer M, Rolling C, Quick H, Schulenkorf A, Lehr C, Bokemeyer C, Beckmann L, Langer F
THROMB RES. 2022;213(Suppl 2):.

Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia Blasts
Beckmann L, Rolling C, Voigtländer M, Mäder J, Klingler F, Schulenkorf A, Lehr C, Bokemeyer C, Ruf W, Langer F
CANCERS. 2021;13(16):3941.

Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome
Beckmann L, Voigtländer M, Holstein K, Lennartz M, Schneider S, Haddad M, Renné T, Bokemeyer C, Rolling C, Langer F
RES PRACT THROMB HAE. 2021;5(5):.

Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA
Beckmann L, Voigtländer M, Rolling C, Schulenkorf A, Bokemeyer C, Langer F
THROMB RES. 2021;2021(203):36-45.

Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Janjetovic S, Beckmann L, Holstein K, Rolling C, Thiele B, Schafhausen P, Schön G, Bokemeyer C, Langer F, Voigtlaender M
THROMB RES. 2021;198:55-61.

LPS-induced expression and release of monocyte tissue factor in patients with haemophilia
Holstein K, Matysiak A, Witt L, Sievers B, Beckmann L, Haddad M, Renné T, Voigtländer M, Langer F
ANN HEMATOL. 2020;99(7):1531-1542.

Effect of myeloperoxidase on the anticoagulant activity of low-molecular-weight heparin and rivaroxaban in an in-vitro tumor model
Voigtländer M, Beckmann L, Schulenkorf A, Sievers B, Rolling C, Bokemeyer C, Langer F
J THROMB HAEMOST. 2020;18(12):3267-3279.

Myeloperoxidase Is a Negative Regulator of Phospholipid-Dependent Coagulation
Beckmann L, Dicke C, Spath B, Lehr C, Sievers B, Klinke A, Baldus S, Rudolph V, Langer F
THROMB HAEMOSTASIS. 2017;117(12):2300-2311.

Letzte Aktualisierung aus dem FIS: 26.07.2024 - 00:38 Uhr